A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
Clinical trial NCT05625919 · UNKNOWN
Trial details
- NCT number
- NCT05625919
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2024-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.